AstraZeneca AB, Merck & Co., Inc. (MRK), Novartis AG, H. Lundbeck A/S, Hoffmann-La Roche AG, And GlaxoSmithKline (GSK) Explore Advances in Solubility, Amorphous Forms and Lipid-Based Formulation of Drugs  
2/4/2010 12:52:53 PM

PHILADELPHIA--(BUSINESS WIRE)--Organized by Pharma IQ, a division of IQPC, the 4th Improving Solubility conference will be held March 29-31, 2010 at The Park Hyatt in Philadelphia, PA. This forum brings together pharmaceutical researchers and scientists to uncover advances in enhancing solubility, amorphous forms, bioavailability & lipid-based formulation of drugs.